TRANSCATHETER AORTIC VALVE IMPLANTATION

This adverse event was reported 111 times

These drugs are most commonly taken by patients reporting TRANSCATHETER AORTIC VALVE IMPLANTATION:

# Drug Count
0 APIXABAN 20
1 CLOPIDOGREL 13
2 ASPIRIN 12
3 RIVAROXABAN 12
4 ASPIRIN 325 MG 11
5 ASPIRIN 81 MG 11
6 FUROSEMIDE 10
7 CLOPIDOGREL BISULFATE 9
8 MACITENTAN 8
9 EVOLOCUMAB 7
See all common drugs associated with TRANSCATHETER AORTIC VALVE IMPLANTATION

TRANSCATHETER AORTIC VALVE IMPLANTATION is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 SODIUM FLUORIDE F18 1 0.0009
1 NATEGLINIDE 1 0.0007
2 APIXABAN 20 0.0003
3 LEVALBUTEROL HYDROCHLORIDE 1 0.0003
4 PENTOXIFYLLINE 1 0.0002
5 TIOTROPIUM BROMIDE AND OLODATEROL 1 0.0002
6 AMANTADINE 2 0.0002
7 EPOPROSTENOL 2 0.0002
8 EDOXABAN TOSYLATE 1 0.0001
9 CICLESONIDE 2 0.0001
See all drugs enriched for association with TRANSCATHETER AORTIC VALVE IMPLANTATION

TRANSCATHETER AORTIC VALVE IMPLANTATION is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Interleukin-5 Antagonist [EPC] 1 0.0015
1 PCSK9 Inhibitor [EPC] 9 0.0003
2 Blood Viscosity Reducer [EPC] 1 0.0002
3 Nonergot Dopamine Agonist [EPC] 2 0.0001
4 Influenza A M2 Protein Inhibitor [EPC] 2 0.0001
5 Factor Xa Inhibitor [EPC] 32 0.0001
6 Prostacyclin Receptor Agonist [EPC] 3 0.0001
7 Glinide [EPC] 1 0.0001
8 Human Immunoglobulin G [EPC] 2 0.0001
9 P2Y12 Platelet Inhibitor [EPC] 7 0.0001
See all drug classes enriched for association with TRANSCATHETER AORTIC VALVE IMPLANTATION